Free Trial
NASDAQ:FONR

FONAR (FONR) Stock Price, News & Analysis

$17.55
+0.15 (+0.86%)
(As of 09/20/2024 ET)

About FONAR Stock (NASDAQ:FONR)

Key Stats

Today's Range
$17.26
$17.55
50-Day Range
$16.22
$18.53
52-Week Range
$12.13
$24.05
Volume
13,345 shs
Average Volume
17,704 shs
Market Capitalization
$111.06 million
P/E Ratio
11.25
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

FONAR Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 49th Percentile

FONAR scored higher than 49% of companies evaluated by MarketBeat, and ranked 588th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of FONAR is 11.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of FONAR is 11.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 143.06.

  • Price to Book Value per Share Ratio

    FONAR has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about FONAR's valuation and earnings.
  • Percentage of Shares Shorted

    0.21% of the float of FONAR has been sold short.
  • Short Interest Ratio / Days to Cover

    FONAR has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in FONAR has recently decreased by 5.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    FONAR does not currently pay a dividend.

  • Dividend Growth

    FONAR does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.21% of the float of FONAR has been sold short.
  • Short Interest Ratio / Days to Cover

    FONAR has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in FONAR has recently decreased by 5.84%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    FONAR has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for FONAR this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for FONR on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, FONAR insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.17% of the stock of FONAR is held by insiders.

  • Percentage Held by Institutions

    50.64% of the stock of FONAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about FONAR's insider trading history.
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

FONR Stock News Headlines

FONAR Co. (NASDAQ:FONR) Sees Large Decline in Short Interest
FONAR (NASDAQ:FONR) Downgraded by StockNews.com to "Buy"
How the US Will Win the Great Lithium Race
China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill.
Deere & Company (DCO0.F)
MSI Sep 2024 410.000 put
BKNG Aug 2024 2940.000 put
See More Headlines

FONR Stock Analysis - Frequently Asked Questions

FONAR's stock was trading at $19.56 at the beginning of 2024. Since then, FONR stock has decreased by 10.3% and is now trading at $17.55.
View the best growth stocks for 2024 here
.

FONAR Co. (NASDAQ:FONR) announced its earnings results on Monday, May, 11th. The medical equipment provider reported $0.18 earnings per share for the quarter. The medical equipment provider earned $21.69 million during the quarter. FONAR had a trailing twelve-month return on equity of 7.50% and a net margin of 10.66%.

FONAR's top institutional investors include Kayne Anderson Rudnick Investment Management LLC (9.64%), Dimensional Fund Advisors LP (6.02%), Renaissance Technologies LLC (5.44%) and Acuitas Investments LLC (1.79%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian.
View institutional ownership trends
.

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC) and Incyte (INCY).

Company Calendar

Last Earnings
5/11/2020
Today
9/20/2024
Next Earnings (Estimated)
9/26/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:FONR
Employees
480
Year Founded
N/A

Profitability

Net Income
$9.38 million
Pretax Margin
19.70%

Debt

Sales & Book Value

Annual Sales
$102.72 million
Cash Flow
$2.97 per share
Book Value
$23.07 per share

Miscellaneous

Free Float
6,191,000
Market Cap
$111.06 million
Optionable
Not Optionable
Beta
1.19
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:FONR) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners